| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 5D6PWO0333 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| BINDING AGENT | Amyloid-beta A4 protein binding agent |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Cognitive Dysfunction | 3 | D060825 | ClinicalTrials |
| Alzheimer Disease | 3 | D000544 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 955085-14-0 |
| ChEMBL | CHEMBL1743072 |
| FDA SRS | 5D6PWO0333 |
| Guide to Pharmacology | 6932 |
CONTENTS